Encompass Health Corporation Payments to Acquire Productive Assets
Encompass Health Corporation (EHC) reported Payments to Acquire Productive Assets of $382.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-08-07
- Encompass Health Corporation payments to acquire productive assets for the quarter ending 2026-06-30 was $220.30M, a 40.41% increase year-over-year.
- Encompass Health Corporation payments to acquire productive assets for the quarter ending 2026-03-31 was $162.40M, a 0.43% decline year-over-year.
- Encompass Health Corporation payments to acquire productive assets for the quarter ending 2025-12-31 was $229.30M, a 15.40% increase year-over-year.
- Encompass Health Corporation payments to acquire productive assets for the quarter ending 2025-09-30 was $187.10M, a 26.85% increase year-over-year.
- Encompass Health Corporation payments to acquire productive assets for fiscal 2025 was $736.40M, a 14.61% increase from fiscal 2024.
- Encompass Health Corporation payments to acquire productive assets for fiscal 2024 was $642.50M, a 10.19% increase from fiscal 2023.
- Encompass Health Corporation payments to acquire productive assets for fiscal 2023 was $583.10M, a 0.17% decline from fiscal 2022.
- Encompass Health Corporation payments to acquire productive assets for fiscal 2022 was $584.10M, a 7.04% increase from fiscal 2021.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 6 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $220.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $382.70M 10-Q · filed 2026-08-07 | $612.00M derived: sum of 3 quarters · filed 2026-08-07 | $799.10M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $162.40M 10-Q · filed 2026-05-01 | $391.70M derived: sum of 2 quarters · filed 2026-05-01 | $578.80M derived: sum of 3 quarters · filed 2026-05-01 | $735.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $229.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $416.40M derived: sum of 2 quarters · filed 2026-02-26 | $573.30M derived: sum of 3 quarters · filed 2026-08-07 | $736.40M 10-K · filed 2026-02-26 |
| 2025-09-30 | $187.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $344.00M derived: sum of 2 quarters · filed 2026-08-07 | $507.10M 10-Q · filed 2025-10-31 | $705.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $156.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $320.00M 10-Q · filed 2026-08-07 | $518.70M derived: sum of 3 quarters · filed 2026-08-07 | $666.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $163.10M 10-Q · filed 2026-05-01 | $361.80M derived: sum of 2 quarters · filed 2026-05-01 | $509.30M derived: sum of 3 quarters · filed 2026-05-01 | $666.20M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $198.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $346.20M derived: sum of 2 quarters · filed 2026-02-26 | $503.10M derived: sum of 3 quarters · filed 2026-02-26 | $642.50M 10-K · filed 2026-02-26 |
| 2024-09-30 | $147.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-31 | $304.40M derived: sum of 2 quarters · filed 2025-10-31 | $443.80M 10-Q · filed 2025-10-31 | $655.50M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $156.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $296.30M 10-Q · filed 2025-08-06 | $508.00M derived: sum of 3 quarters · filed 2026-02-26 | $657.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $139.40M 10-Q · filed 2025-05-01 | $351.10M derived: sum of 2 quarters · filed 2026-02-26 | $500.80M derived: sum of 3 quarters · filed 2026-02-26 | $622.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $211.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $361.40M derived: sum of 2 quarters · filed 2026-02-26 | $483.30M derived: sum of 3 quarters · filed 2026-02-26 | $583.10M 10-K · filed 2026-02-26 |
| 2023-09-30 | $149.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | $271.60M derived: sum of 2 quarters · filed 2024-11-01 | $371.40M 10-Q · filed 2024-11-01 | |
| 2023-06-30 | $121.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $221.70M 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $99.80M 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $584.10M 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $545.70M 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |